Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

On drug artifacts in middle molecule analysis.

H Asaba, L Zimmerman, J Bergström

    Nephron
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dialysis, ultrafiltration, and blood pressure. 1976.

    Blood purification·2006
    Same author

    Inflammation, malnutrition, cardiovascular disease and mortality in end-stage renal disease.

    Polskie Archiwum Medycyny Wewnetrznej·2001
    Same author

    Smoking and subgingival microflora in periodontal disease.

    Journal of clinical periodontology·2001
    Same author

    Fluid and solute transport using different sodium concentrations in peritoneal dialysis solutions.

    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2001
    Same author

    Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001
    Same author

    Biocompatibility of new peritoneal dialysis solutions: what can we hope to achieve?

    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2001
    Same journal

    The Impact of High-Altitude Acclimatization on Frontal Lobe Executive Function: The Mediating Effect of Creatinine.

    Nephron·2026
    Same journal

    Expert Commentary of the Recent International Pediatric Nephrology Association IgA Vasculitis Nephritis Guidelines.

    Nephron·2026
    Same journal

    Acute effects of exercise on the nephron index under different conditions in middle-aged males - a preliminary study.

    Nephron·2026
    Same journal

    Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases.

    Nephron·2026
    Same journal

    Prevalence of COVID-19 Pneumonia and Clinical Characteristics in Hemodialysis Patients During the SARS-CoV-2 Omicron Pandemic.

    Nephron·2026
    Same journal

    Real-World Outcomes of Patients with Monoclonal Gammopathy of Renal Significance.

    Nephron·2026
    See all related articles

    Common medications like furosemide do not interfere with plasma middle molecule testing in uremic patients. However, salicylic acid

    Area of Science:

    • Nephrology and Clinical Chemistry

    Background:

    • Plasma middle molecules are important indicators in kidney disease.
    • Certain medications may interfere with laboratory test results, potentially affecting patient diagnosis and management.

    Purpose of the Study:

    • To investigate potential artifacts in plasma middle molecule determination caused by common medications in uremic patients.
    • To assess the impact of specific drugs on the accuracy of middle molecule measurements.

    Main Methods:

    • Retrospective analysis of 58 nondialyzed uremic patients.
    • Evaluation of plasma samples from hemodialysis patients.
    • Administration of salicylic acid to normal subjects and analysis of urinary excretion.

    Main Results:

    • No artifacts were substantiated for furosemide, methyldopa, hydralazine, allopurinol, and beta-blocking agents in plasma middle molecule determination.

    Related Experiment Videos

  • Furosemide did not influence middle molecule determination in hemodialysis patients.
  • Salicylic acid increased urinary excretion of fraction 7c in normal subjects, warranting further investigation.

    • Conclusions:

    • Commonly used medications do not appear to interfere with plasma middle molecule testing in nondialyzed uremic patients.
    • The effect of salicylic acid on urinary excretion requires further study to understand its clinical significance.